AP3486A - Preparation method of new recombinant antibacterial polypeptide medicine - Google Patents

Preparation method of new recombinant antibacterial polypeptide medicine

Info

Publication number
AP3486A
AP3486A AP2013007193A AP2013007193A AP3486A AP 3486 A AP3486 A AP 3486A AP 2013007193 A AP2013007193 A AP 2013007193A AP 2013007193 A AP2013007193 A AP 2013007193A AP 3486 A AP3486 A AP 3486A
Authority
AP
ARIPO
Prior art keywords
preparation
new recombinant
antibacterial polypeptide
recombinant antibacterial
polypeptide medicine
Prior art date
Application number
AP2013007193A
Other languages
English (en)
Other versions
AP2013007193A0 (en
Inventor
Rongqi Li
Xiangli Zhang
Xiaofeng Zhang
Original Assignee
Creative Trio Biotech Beijing Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Creative Trio Biotech Beijing Co Ltd filed Critical Creative Trio Biotech Beijing Co Ltd
Publication of AP2013007193A0 publication Critical patent/AP2013007193A0/xx
Application granted granted Critical
Publication of AP3486A publication Critical patent/AP3486A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AP2013007193A 2011-03-04 2012-03-01 Preparation method of new recombinant antibacterial polypeptide medicine AP3486A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN201110052238.5A CN102653779B (zh) 2011-03-04 2011-03-04 一种新型重组抗菌多肽药物的制备方法
PCT/CN2012/071825 WO2012119524A1 (zh) 2011-03-04 2012-03-01 一种新型重组抗菌多肽药物的制备方法

Publications (2)

Publication Number Publication Date
AP2013007193A0 AP2013007193A0 (en) 2013-10-31
AP3486A true AP3486A (en) 2015-12-31

Family

ID=46729509

Family Applications (1)

Application Number Title Priority Date Filing Date
AP2013007193A AP3486A (en) 2011-03-04 2012-03-01 Preparation method of new recombinant antibacterial polypeptide medicine

Country Status (18)

Country Link
US (1) US9765378B2 (xx)
EP (1) EP2682474B1 (xx)
JP (1) JP5916769B2 (xx)
KR (1) KR101566331B1 (xx)
CN (1) CN102653779B (xx)
AP (1) AP3486A (xx)
AU (1) AU2012225088B2 (xx)
BR (1) BR112013022333A2 (xx)
CA (1) CA2828998A1 (xx)
CL (1) CL2013002534A1 (xx)
CO (1) CO6771436A2 (xx)
EA (1) EA030794B1 (xx)
HK (1) HK1169837A1 (xx)
MY (1) MY169503A (xx)
SG (1) SG193000A1 (xx)
TW (1) TWI541351B (xx)
WO (1) WO2012119524A1 (xx)
ZA (1) ZA201306575B (xx)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103131724B (zh) 2011-11-25 2015-02-25 畿晋庆三联（北京）生物技术有限公司 一种高效表达工程菌重组蛋白的方法及应用
WO2014150451A1 (en) * 2013-03-15 2014-09-25 Merial Limited Antimicrobial polyamide compositions and mastitis treatment
CN104328080A (zh) * 2014-08-04 2015-02-04 湖北文理学院 大肠埃希菌atcc25922增殖促进剂及其应用方法

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1712534A (zh) * 2004-06-25 2005-12-28 私立逢甲大学 用以增进重组蛋白质的生产的核酸构建体与表达载体以及用以大量生产重组蛋白质的方法
CN101643501A (zh) * 2008-11-07 2010-02-10 畿晋庆三联（北京）生物技术有限公司 一种新型抗生素及其核苷酸序列、制备方法与应用
CN101914603A (zh) * 2010-07-08 2010-12-15 暨南大学 利用乳糖诱导pMFH载体生产重组蛋白的发酵方法

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3737157B2 (ja) * 1994-07-11 2006-01-18 協和醗酵工業株式会社 光学活性γ−ヒドロキシ−Ｌ−グルタミン酸の製造法
RU2095409C1 (ru) * 1995-06-27 1997-11-10 Всероссийский научно-исследовательский институт ветеринарной вирусологии и микробиологии Способ изготовления вакцины против сибирской язвы животных
US6995297B1 (en) * 1999-07-13 2006-02-07 Deuk Hun Ahn Herb medicine composition to be contained in sanitary materials for infants
RU2203948C2 (ru) * 1999-10-28 2003-05-10 Закрытое акционерное общество "Научно-исследовательский институт Аджиномото-Генетика" Штамм бактерий corynebacterium ammoniagenes - продуцент уридин-5'-монофосфата (варианты), способ получения уридин-5'- монофосфата
CN1164612C (zh) * 2001-09-11 2004-09-01 四川新泰克控股有限责任公司 人工组合的抗菌工程多肽及其制备方法
CN1412312A (zh) * 2002-08-21 2003-04-23 重庆康尔威药业股份有限公司 重组人快速骨骼肌型肌钙蛋白c在大肠杆菌中的表达及其在抗肿瘤治疗中的应用
US8212110B2 (en) * 2003-05-14 2012-07-03 Integrated Plant Genetics, Inc. Use of bacteriophage outer membrane breaching proteins expressed in plants for the control of gram-negative bacteria
WO2005019417A2 (en) * 2003-08-14 2005-03-03 The Bio Balance Corporation Bacterial strains, compositions including same and probiotic use thereof
BRPI0608152A2 (pt) * 2005-02-09 2009-11-10 Macusight Inc formulações para tratamento ocular
WO2007136553A2 (en) * 2006-05-18 2007-11-29 Biobalance Llc Bacterial strains, compositions including same and probiotic use thereof
BRPI0722315A2 (pt) * 2007-12-28 2014-06-10 Roquette Freres Método de cultura microbiana em larga escala
EP2294193A4 (en) * 2008-04-10 2012-11-28 Dsm Ip Assets Bv PRODUCTION OF CAROTENOIDS IN YEAST AND OLEAGINOUS FUNGI
CN101503659B (zh) * 2009-03-11 2011-03-23 中国农业大学 一种哈茨木霉菌株及其应用
US20130295171A1 (en) * 2009-07-23 2013-11-07 U.S NUTRACEUTICALS, LLC d/b/a Valensa International Krill oil and reacted astaxanthin composition and associated method
CN101974548A (zh) * 2010-08-20 2011-02-16 中国农业大学 一种表达重组nisin-rbLF-N融合基因的大肠杆菌工程菌
US8563503B2 (en) * 2011-02-07 2013-10-22 Protein Design Lab. Ltd. Antibiotic, its nucleotide sequence, methods of construction and uses thereof
US8609110B2 (en) * 2011-06-21 2013-12-17 University of Pittsburgh—of the Commonwealth System of Higher Education Citrobacter freundii antibacterial agents and their use

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1712534A (zh) * 2004-06-25 2005-12-28 私立逢甲大学 用以增进重组蛋白质的生产的核酸构建体与表达载体以及用以大量生产重组蛋白质的方法
CN101643501A (zh) * 2008-11-07 2010-02-10 畿晋庆三联（北京）生物技术有限公司 一种新型抗生素及其核苷酸序列、制备方法与应用
CN101914603A (zh) * 2010-07-08 2010-12-15 暨南大学 利用乳糖诱导pMFH载体生产重组蛋白的发酵方法

Also Published As

Publication number Publication date
MY169503A (en) 2019-04-15
US20160304927A1 (en) 2016-10-20
EP2682474B1 (en) 2017-05-10
SG193000A1 (en) 2013-10-30
JP5916769B2 (ja) 2016-05-11
ZA201306575B (en) 2016-03-30
EP2682474A1 (en) 2014-01-08
EA201300884A8 (ru) 2018-06-29
CA2828998A1 (en) 2012-09-13
TWI541351B (zh) 2016-07-11
EA201300884A1 (ru) 2014-04-30
CN102653779B (zh) 2014-02-19
NZ614593A (en) 2015-07-31
JP2014508766A (ja) 2014-04-10
HK1169837A1 (en) 2013-02-08
TW201239092A (en) 2012-10-01
AU2012225088B2 (en) 2015-04-09
US9765378B2 (en) 2017-09-19
CO6771436A2 (es) 2013-10-15
KR101566331B1 (ko) 2015-11-05
CL2013002534A1 (es) 2014-07-11
EA030794B1 (ru) 2018-09-28
AP2013007193A0 (en) 2013-10-31
AU2012225088A1 (en) 2013-09-12
CN102653779A (zh) 2012-09-05
WO2012119524A1 (zh) 2012-09-13
EP2682474A4 (en) 2014-12-10
KR20130138822A (ko) 2013-12-19
BR112013022333A2 (pt) 2016-12-06

Similar Documents

Publication Publication Date Title
IL282393B (en) Production of heterodimeric proteins
IL279676A (en) Recombinant proteins and therapeutic uses
SG11201400432VA (en) Polypeptide vaccine
EP2668272A4 (en) METHOD FOR PRODUCING RECOMBINANT HUMAN IDURONATE-2-SULFATASE
HK1209790A1 (en) Method of producing recombinant iduronate-2-sulfatase -2-
SG11201403814RA (en) Production of recombinant proteins with simple glycoforms
EP2788014A4 (en) USE OF GROWTH HORMONE FRAGMENTS
GB201208293D0 (en) Hydrochlorice salt of peptide
EP2792745A4 (en) MODIFICATION OF POLYPEPTIDE INDUCING AUXILIARY T CELLS
EP2877575A4 (en) PROCESS FOR PRODUCING RECOMBINANT HUMAN ALPHA-GALACTOSIDASE A
AP3486A (en) Preparation method of new recombinant antibacterial polypeptide medicine
EP2695947A4 (en) PROCESS FOR PRODUCING RECOMBINANT POLYPEPTIDE
HK1203475A1 (en) Processes for the preparation of stannic oxide
EP3560952C0 (en) VARIANT OF BPIFB4 PROTEIN
SG11201405721VA (en) Method of producing a recombinant peptide
EP2688913A4 (en) HIGH PERFORMANCE PRODUCTION OF RECOMBINANT PROTEINS
IL235052B (en) A method for increasing the secretion of recombinant proteins
ZA201404698B (en) Use of growth hormone fragments
ME03515B (me) Proizvodnja heterodimernih proteina